Outflow cannula alignment in continuous flow left ventricular devices is associated with stroke.

Outflow cannula, left ventricular devices, stroke artificial kidney, apheresis, & detoxification techniques artificial kidney, apheresis, & detoxification techniques, echocardiography, cardiac computed tomography, cardiac imaging

Journal

The International journal of artificial organs
ISSN: 1724-6040
Titre abrégé: Int J Artif Organs
Pays: United States
ID NLM: 7802649

Informations de publication

Date de publication:
Apr 2023
Historique:
medline: 12 4 2023
pubmed: 11 3 2023
entrez: 10 3 2023
Statut: ppublish

Résumé

We sought to evaluate whether differences in left ventricular assist device (LVAD) canula alignment are associated with stroke. There is a paucity of clinical data on contribution of LVAD canulae alignment to strokes. We conducted a retrospective analysis of patients who underwent LVAD implantation at Houston Methodist hospital from 2011 to 2016 and included those who had undergone cardiac computed tomography (CT) with contrast. LVAD graft alignment using X-ray, echocardiography, and cardiac CT was evaluated. The primary outcome was stroke within 1 year of LVAD implantation. Of the 101 patients that underwent LVAD Implantation and cardiac CT scan during the study period, 78 met inclusion criteria. The primary outcome occurred in 12 (15.4%) patients with a median time to stroke of 77 days (interquartile range: 42-132 days). Of these, 10 patients had an ischemic and two had hemorrhagic strokes. The predominant device type was Heart Mate II (94.8%). Patients with LVAD outflow cannula to aortic angle lesser than 37.5° and those with outflow graft diameter of anastomosis less than 1.5 cm (assessed by cardiac CT) had significantly higher stroke risk (

Identifiants

pubmed: 36895175
doi: 10.1177/03913988231154284
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

226-234

Auteurs

Mahwash Kassi (M)

Houston Methodist Hospital, Houston, TX, USA.

Tanushree Agrawal (T)

Houston Methodist Hospital DeBakey Cardiology Associates, Houston, TX, USA.

Jiaqiong Xu (J)

Houston Methodist Research Institute, Houston, TX, USA.

Hernan Gerardo Marcos-Abdala (HG)

Houston Methodist Research Institute, Houston, TX, USA.

Raquel Araujo-Gutierrez (R)

Houston Methodist Hospital, Houston, TX, USA.

Thomas Macgillivray (T)

Houston Methodist Hospital, Houston, TX, USA.

Erik E Suarez (EE)

Houston Methodist Research Institute, Houston, TX, USA.

Rayan Yousefzai (R)

Houston Methodist, Houston, TX, USA.

Nadia Fida (N)

Houston Methodist Hospital, Houston, TX, USA.

Ju H Kim (JH)

Houston Methodist Hospital, Houston, TX, USA.

Imad Hussain (I)

Houston Methodist DeBakey Heart & Vascular Center, Houston, TX, USA.

Ashrith Guha (A)

Houston Methodist Hospital DeBakey Cardiology Associates, Houston, TX, USA.

Barry Trachtenberg (B)

Houston Methodist Hospital DeBakey Cardiology Associates, Houston, TX, USA.

Arvind Bhimaraj (A)

Houston Methodist Hospital DeBakey Cardiology Associates, Houston, TX, USA.

Su Min Chang (SM)

Houston Methodist Hospital DeBakey Cardiology Associates, Houston, TX, USA.

Jerry Estep (J)

Cleveland Clinic Foundation, Cleveland, OH, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH